obesity drug news today glp-1 2025 oct 27 Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford The Obesity-Drug Revolution Is Stalling

doi: 10.1016/j.xcrm.2021.100263 [DOI] [PMC free article] [PubMed] [Google Scholar] 74

We did not include any case reports, abstracts without full texts, and works that did not focus on the relevant therapeutic agents or pain models

These successes are even more pronounced in those treated with tirzepatide, with nearly 60% of patients losing 20% of their weight and nearly 40% losing even more than 25% of their initial weight (Figure 6B)

Combining liraglutide therapy with exercise further enhanced outcomes, leading to more significant weight loss, improved insulin sensitivity, and better cardiovascular fitness than either intervention alone (36)

The pathomorphological alterations of endocardial endothelium in experimental diabetes and diabetes associated with hyperlipidemiaPubMed [cited 2024 Jul 24]